Results

Janssen Pharmaceuticals Inc.

07/30/2020 | Press release | Distributed by Public on 07/30/2020 20:39

U.S. Food and Drug Administration Approves STELARA® (ustekinumab) for Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis